Search clinical trials for: Insulin Glargine (U100)
Total 4960 results
-
Guillermo UmpierrezCompleted
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Nordsjaellands HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedType 1 Diabetes Mellitus | Nocturnal Hypoglycemia | Recurrent Severe HypoglycaemiaDenmark
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Fudan UniversityShanghai Changzheng Hospital; Shanghai 6th People's Hospital; Shanghai Minhang... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Non-alcoholic Fatty Liver DiseaseChina
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
Cliniques universitaires Saint-Luc- Université...CompletedType 1 DiabetesBelgium
-
The First Affiliated Hospital of Xiamen UniversityUnknownOverweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes PatientsChina
-
AstraZenecaEli Lilly and CompanyCompleted
-
SanofiCompleted
-
Population Health Research InstituteHamilton Health Sciences CorporationCompletedType 2 Diabetes MellitusCanada
-
Emory UniversityCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Completed
-
SanofiCompletedDiabetes Mellitus, Type 2France, Russian Federation, Croatia, Slovenia, Czech Republic, Romania
-
Rush University Medical CenterWithdrawn
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
Institut de Recherches Cliniques de MontrealNovo Nordisk A/S; McMaster UniversityCompleted
-
Vancouver General HospitalTerminatedPost-Transplant Glucocorticoid Induced DiabetesCanada
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Riverside University Health System Medical CenterTerminated
-
Cairo UniversitySanofiUnknownLiver Cirrhosis | Type 2 DiabetesEgypt
-
Novo Nordisk A/SCompleted
-
Emory UniversityCompletedDiabetes Mellitus | Type 1 DiabetesUnited States
-
Stanford UniversityUniversity of Colorado, Denver; BiodelWithdrawnDiabetes MellitusUnited States
-
Assaf-Harofeh Medical CenterTerminated
-
University Hospital TuebingenWithdrawn
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompletedDiabetes MellitusSweden, Finland, Netherlands, United Kingdom
-
Hoffmann-La RocheTerminatedDiabetes Mellitus Type 2China, Hong Kong, Korea, Republic of, Philippines, Taiwan, Malaysia, Thailand
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States
-
SanofiCompleted
-
University of Colorado, DenverCompletedType 1 Diabetes Mellitus | Diabetic KetoacidosisUnited States
-
Loyola UniversitySanofiCompletedRenal Insufficiency | Type 2 DiabetesUnited States
-
Dr. Muhammad AbdulghaniUnknown
-
Eli Lilly and CompanyCompleted
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2China
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
SanofiCompleted